Overall Assessment: The stock has demonstrated significant volatility over the past six months, with a notable rally from around $90 in October 2025 to a peak above $140 in January 2026, followed by a sharp correction. The 6-month price change is +21.35%, indicating a strong overall uptrend despite recent weakness. Short-term Performance: The stock has experienced substantial recent pressure, declining 13.42% over the past month and 10.97% over the past three months. This underperforms the broader market, as indicated by negative relative strength figures of -8.17 and -6.34 against the S&P 500 for the respective periods. Current Position: The current price of $109.51 sits approximately 23% below its 52-week high of $142.40 and about 77% above its 52-week low of $61.87. This places the stock in the upper-mid range of its yearly trading band, having retreated significantly from its recent highs.

Revenue & Profitability: The latest quarterly revenue (Q4 2025) was $5.45 billion, representing a year-over-year growth of 9.02%. Profitability has shown strong improvement, with the net margin for the quarter at 9.29%, a significant recovery from negative margins in the prior year's comparable quarter. Financial Health: The company's debt-to-equity ratio is elevated at 1.23, indicating a leveraged balance sheet. However, cash flow generation appears robust, with trailing twelve-month free cash flow reported at $1.40 billion, supporting financial flexibility. Operational Efficiency: Return on Equity (ROE) is strong at 34.16%, indicating effective use of shareholder capital. The current ratio is 1.07, suggesting adequate, though not excessive, short-term liquidity to cover obligations.